• hlooho_banner_01

Motixafortide

Tlhaloso e Khutšoanyane:

Motixafortide ke peptide ea mohanyetsi oa CXCR4 e entsoeng ho bokella lisele tsa stem tsa hematopoietic (HSCs) bakeng sa phetisetso ea autologous mme e ntse e ithutoa ho oncology le immunotherapy.


Lintlha tsa Sehlahisoa

Li-tag tsa Sehlahisoa

Motixafortide API

Motixafortide ke peptide ea mohanyetsi oa CXCR4 e entsoeng ho bokella lisele tsa stem tsa hematopoietic (HSCs) bakeng sa phetisetso ea autologous mme e ntse e ithutoa ho oncology le immunotherapy.

Mokhoa le Lipatlisiso:

Motixafortide e thibela axis ea CXCR4-SDF-1, e lebisang ho:
Ho bokellana ha lisele tsa stem ka potlako maling a peripheral
Tšebeliso e matla ea lisele tsa 'mele le ho kenella ha tumor
Tšebelisano e ka bang teng le li-checkpoint inhibitors le chemotherapy

E bontšitse lihlahisoa tse phahameng tsa stem cell ha li bapisoa le bahlaseli ba teng litekong tsa meriana.
Likarolo tsa API (Gentolex Group):

Peptide ea maiketsetso e phahameng e hloekileng
Litekanyetso tsa tlhahiso tse kang GMP
E loketse litlhare tse nang le ente

Motixafortide API e tšehetsa lipatlisiso tse tsoetseng pele ho stem cell therapy le immunotherapy ea mofetše.


  • E fetileng:
  • E 'ngoe:

  • Ngola molaetsa wa hao mona mme o re romele wona